TNFSF14 and neoplasm: Following intravenous (i.v.)injection, PαCD3&LIGHT crosses various physiological barriers and specifically expresses in tumor cells but not in normal cells, resulting in the abundant secretion of tumor necrosis factor superfamily member 14 (LIGHT) and the decoration of anti-CD3 scFv-B7 fusion protein (αCD3) on tumor cell surface.